back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2021-10-19 10:43 Tx date 2021-10-19 |
$RLSC
RISE Life Science Corp. |
Secord, Scott Lawrence
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$449,200
+8,984,000 vol $0.05 each |
40,205,500 | |
| Filed 2021-08-26 13:47 Tx date 2021-08-24 |
$RLSC
RISE Life Science Corp. |
Secord, Scott Lawrence
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$650,160
+30,960,000 vol $0.021 each |
31,960,000 | |
| Filed 2021-08-26 13:43 Tx date 2021-08-24 |
$RLSC
RISE Life Science Corp. |
Secord, Scott Lawrence
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$464,400
+30,960,000 vol $0.015 each |
31,221,500 | |
| Filed 2021-08-26 13:41 Tx date 2021-08-24 |
$RLSC
RISE Life Science Corp. |
Secord, Scott Lawrence
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$46,440
+3,096,000 vol $0.015 each |
||
| Filed 2019-05-13 09:54 Tx date 2019-05-10 |
$RLSC
RISE Life Science Corp. |
Secord, Scott Lawrence
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,190
+7,000 vol $0.17 each |
261,500 | |
| Filed 2019-05-06 09:07 Tx date 2019-05-03 |
$RLSC
RISE Life Science Corp. |
Secord, Scott Lawrence
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,600
+20,000 vol $0.18 each |
254,500 | |
| Filed 2019-02-18 Tx date 2019-01-29 |
$RLSC
RISE Life Science Corp. |
Mills, James Gregory
4 - Director of Issuer
Direct Ownership
|
Convertible Notes
00 - Opening Balance-Initial SEDI Report
|
$200,000 | ||
| Filed 2019-02-07 Tx date 2019-02-07 |
$RLSC
RISE Life Science Corp. |
Secord, Scott Lawrence
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,275
+15,000 vol $0.285 each |
234,500 | |
| Filed 2019-02-07 Tx date 2019-02-05 |
$RLSC
RISE Life Science Corp. |
Secord, Scott Lawrence
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,400
+30,000 vol $0.28 each |
219,500 | |
| Filed 2019-02-01 Tx date 2019-02-01 |
$RLSC
RISE Life Science Corp. |
Secord, Scott Lawrence
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,500
+10,000 vol $0.25 each |
189,500 | |
| Filed 2019-01-31 Tx date 2019-01-29 |
$RLSC
RISE Life Science Corp. |
Mills, James Gregory
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
| Filed 2019-01-29 Tx date 2019-01-25 |
$RLSC
RISE Life Science Corp. |
Secord, Scott Lawrence
4 - Director of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
$150,000
+1,000,000 vol $0.15 each |
1,000,000 | |
| Filed 2019-01-29 Tx date 2019-01-28 |
$RLSC
RISE Life Science Corp. |
Secord, Scott Lawrence
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,194
+79,000 vol $0.205 each |
179,500 | |
| Filed 2019-01-29 Tx date 2018-10-03 |
$RLSC
RISE Life Science Corp. |
Secord, Scott Lawrence
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-13 Tx date 2018-12-13 |
$RLSC
RISE Life Science Corp. |
Secord, Scott Lawrence
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,125
+7,500 vol $0.15 each |
80,500 | |
| Filed 2018-12-13 Tx date 2018-12-11 |
$RLSC
RISE Life Science Corp. |
Secord, Scott Lawrence
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,400
+15,000 vol $0.16 each |
73,000 | |
| Filed 2018-12-13 Tx date 2018-12-13 |
$RLSC
RISE Life Science Corp. |
Secord, Scott Lawrence
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,800
+20,000 vol $0.14 each |
100,500 | |
| Filed 2018-12-10 Tx date 2018-12-10 |
$RLSC
RISE Life Science Corp. |
Secord, Scott Lawrence
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,249
+50,000 vol $0.145 each |
58,000 | |
| Filed 2018-12-07 Tx date 2018-10-03 |
$RLSC
RISE Life Science Corp. |
Secord, Scott Lawrence
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-07 Tx date 2018-12-06 |
$RLSC
RISE Life Science Corp. |
Secord, Scott Lawrence
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,120
+8,000 vol $0.14 each |
8,000 | |
| Filed 2018-09-16 Tx date 2018-09-12 |
$RLSC
RISE Life Science Corp. |
Mattadeen, Anton Raynor
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-125,000 vol |
5,139,800 | |
| Filed 2018-09-16 Tx date 2018-09-12 |
$RLSC
RISE Life Science Corp. |
Mattadeen, Anton Raynor
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-250,000 vol |
5,389,800 | |
| Filed 2018-09-16 Tx date 2018-09-12 |
$RLSC
RISE Life Science Corp. |
Mattadeen, Anton Raynor
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-125,000 vol |
5,264,800 | |
| Filed 2018-09-15 Tx date 2018-09-12 |
$RLSC
RISE Life Science Corp. |
Dollard, Christopher Hugh
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-125,000 vol |
4,782,300 | |
| Filed 2018-09-15 Tx date 2018-09-12 |
$RLSC
RISE Life Science Corp. |
Dollard, Christopher Hugh
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-125,000 vol |
4,657,300 | |
| Filed 2018-09-15 Tx date 2018-09-12 |
$RLSC
RISE Life Science Corp. |
Dollard, Christopher Hugh
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-250,000 vol |
4,907,300 | |
| Filed 2018-09-12 Tx date 2018-02-27 |
$RLSC
RISE Life Science Corp. |
Campbell, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-09-12 Tx date 2018-09-12 |
$RLSC
RISE Life Science Corp. |
Campbell, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+500,000 vol |
500,000 | |
| Filed 2018-08-13 Tx date 2018-08-03 |
$RLSC
RISE Life Science Corp. |
Campbell, Michael
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
500,000 | |
| Filed 2018-08-13 Tx date 2018-02-27 |
$RLSC
RISE Life Science Corp. |
Campbell, Michael
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-08-08 Tx date 2018-08-03 |
$RLSC
RISE Life Science Corp. |
Dollard, Christopher Hugh
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$150,000
+500,000 vol $0.30 each |
500,000 | |
| Filed 2018-08-08 Tx date 2018-08-03 |
$RLSC
RISE Life Science Corp. |
Mattadeen, Anton Raynor
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$150,000
+500,000 vol $0.30 each |
500,000 | |
| Filed 2018-08-08 Tx date 2018-02-05 |
$RLSC
RISE Life Science Corp. |
Dollard, Christopher Hugh
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-08-08 Tx date 2017-09-28 |
$RLSC
RISE Life Science Corp. |
Mattadeen, Anton Raynor
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-08-07 Tx date 2018-03-02 |
$RLSC
RISE Life Science Corp. |
Lelovic, Robert Arthur
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-08-07 Tx date 2018-08-03 |
$RLSC
RISE Life Science Corp. |
Lelovic, Robert Arthur
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$150,000
+500,000 vol $0.30 each |
500,000 | |
| Filed 2018-07-07 Tx date 2018-06-29 |
$RLSC
RISE Life Science Corp. |
Lelovic, Robert Arthur
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$9,999
+33,333 vol $0.30 each |
66,666 | |
| Filed 2018-07-07 Tx date 2018-06-29 |
$RLSC
RISE Life Science Corp. |
Lelovic, Robert Arthur
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$7,499
+16,666 vol $0.45 each |
33,332 | |
| Filed 2018-04-10 Tx date 2018-03-02 |
$RLSC
RISE Life Science Corp. |
Lelovic, Robert Arthur
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-04-10 Tx date 2018-04-10 |
$RLSC
RISE Life Science Corp. |
Lelovic, Robert Arthur
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
+33,333 vol |
33,333 | |
| Filed 2018-04-10 Tx date 2018-03-02 |
$RLSC
RISE Life Science Corp. |
Lelovic, Robert Arthur
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-04-10 Tx date 2018-04-10 |
$RLSC
RISE Life Science Corp. |
Lelovic, Robert Arthur
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$7,499
+16,666 vol $0.45 each |
16,666 | |
| Filed 2018-04-03 Tx date 2018-04-02 |
$RLSC
RISE Life Science Corp. |
Dollard, Christopher Hugh
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
47 - Acquisition or disposition by gift
|
$-52,700
-170,000 vol $0.31 each |
5,157,300 |